New treatments for mental illness promise better treatment outcomes for our patients. Novel antidepressants, new mood stabilizers, brain stimulation treatments, and innovative psychotherapies all are effective in clinical trials, but how do they work in "the real world"? How can we utilize these new treatments, individually or in combination, to treat the most challenging illnesses? What are the most effective approaches to treatment-resistant bipolar disorder, to comorbid depression and substance abuse, and to borderline personality disorder? This is a time of rapid change in psychiatry - how do we use recent advances to achieve better outcomes for treatment-resistant illness?

UCLA's 19th Annual Review of Psychiatry and Psychopharmacology Update will address the most challenging questions in mental health treatment today. Our expert faculty will review the latest studies that can help shape your treatment decisions. The conference will take place on Friday, November 7th, and Saturday, November 8th, 2014 at The Skirball Cultural Center in Los Angeles. Leaders in the field of mental health will be sharing their expertise on diagnosis and treatment of depression, schizophrenia, ADHD, addictions, borderline personality, and bipolar disorder.

Course Chair: Andrew F. Leuchter, M.D.


  • Registration for the live, two-day conference is $295 for up to 14 CME credits.
  • For an additional $95 you can view the supplementary lectures online, earn 6 more credits, and receive access to last year's entire program.